FDA approves first rapid-acting insulin biosimilar for patients with diabetes
Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...
Endocrinology Advisor1d
FDA Approves Merilog, a Rapid-Acting Insulin Biosimilar Product
The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.
pharmaphorum3y
FDA okays Viatris' insulin drug as first 'interchangeable' biosimilar
Biosimilars marketed in the US typically have list prices 15% to 35% lower than ... if needed – at mealtimes for example – with fast-acting insulins. The cost of insulin products has become ...
pharmaphorum4d
Lilly slashes insulin price 70%, patient cost cap now $35
List prices for drugs often differ from what ... Both Humalog and Insulin Lispro Injection are fast-acting insulins, they are used to control high blood sugar in adults and children with diabetes ...
Interesting Engineering on MSN2d
FDA approves first-ever rapid-acting insulin biosimilar for diabetes treatment
The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...
MedPage Today7d
FDA OKs First Rapid-Acting Insulin Biosimilar for Diabetes
Opens in a new tab or window The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and children with diabetes, the agency announced ...
Yahoo Finance6d
FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes
Merilog, a rapid-acting human insulin analog, is the first rapid-acting insulin biosimilar product approved by the FDA. As a rapid-acting insulin, Merilog helps to lower mealtime blood sugar ...